Patents Assigned to Sartar Therapeutics Ltd
  • Compositions comprising phosphodiesterase inhibitors for use in the treatment of a solid tumor in a human patient
    Patent number: 9901579
    Abstract: The present invention is related to a composition comprising a phosphodiesterase inhibitor, such as anagrelide or a salt thereof, for use in the treatment of a solid tumor, such as gastrointestinal stromal tumor (GIST) or a liposarcoma, which express phosphodiesterase 3 enzymes, in a human patient.
    Type: Grant
    Filed: October 17, 2014
    Date of Patent: February 27, 2018
    Assignee: Sartar Therapeutics Ltd
    Inventors: Harri Sihto, Olli-Pekka Pulkka, Olli Kallioniemi, Heikki Joensuu